In preclinical models of NASH-induced HCC, CD8+ T cells accumulate in the liver with phenotypes combined tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD-1). The gene discussed is CD8A; the disease is hepatocellular carcinoma.